NS 2664

Drug Profile

NS 2664

Latest Information Update: 13 Jul 2006

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator NeuroSearch
  • Class Antiepileptic drugs; Neuroprotectants
  • Mechanism of Action GABA-A receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Complex partial epilepsy

Most Recent Events

  • 13 Jul 2006 Discontinued - Preclinical for Complex partial seizures in Denmark (unspecified route)
  • 03 Dec 2003 A preclinical study has been added to the Epilepsy pharmacodynamics section
  • 27 Nov 2003 Preclinical trials in Complex partial seizures in Denmark (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top